Transgrediens et progrediens palmoplantar keratoderma (Mal de Meleda): A Patient Guide
At a Glance
Mal de Meleda is a rare genetic condition that progressively thickens the palms and soles and may spread to nearby skin. Clinical assessment and genetic testing help confirm the diagnosis, while skin-softening care, protective footwear, and specialist follow-up help preserve comfort and mobility.
Transgrediens et progrediens palmoplantar keratoderma, most frequently referred to as Mal de Meleda, is an exceptionally rare genetic skin condition characterized by the significant thickening of the skin on the palms of the hands and the soles of the feet [1]. Unlike other forms of skin thickening that stay confined to the palms and soles, this condition is “transgredient,” meaning the waxy, yellowish plaques often “cross over” the edges to affect the backs of the hands, the tops of the feet, and the skin around the wrists, ankles, elbows, and knees [2]. Because it is a “progrediens” or progressive condition, it typically begins in early infancy and becomes more pronounced as a person grows into adulthood [3].
At its core, Mal de Meleda is caused by a disruption in how skin cells mature and shed, a process regulated by specific genes like SLURP1 [4]. Because the symptoms can overlap with several other rare skin disorders, obtaining a diagnosis through clinical evaluation and genetic testing is a vital step in your journey [5]. Confirming the specific genetic mutation helps your care team understand the inheritance pattern and provides essential information for family planning [6]. However, it is important to know that genetic testing cannot always predict your exact disease course, as individual severity and progression vary.
Living with this condition requires a proactive and consistent approach to management, focusing on both the physical thickening and the secondary effects of moisture and friction. Excessive sweating, trapped moisture, and the development of painful cracks or fissures are common challenges that can impact your comfort and ability to move freely [7]. However, with a dedicated routine involving topical skin-softening agents, specialized footwear, and, in some cases, oral medications, the most burdensome symptoms can be effectively managed [8][9].
While Mal de Meleda presents lifelong challenges, you are not alone in navigating them. A multidisciplinary approach—combining the expertise of dermatologists, podiatrists, and genetic counselors—ensures that you can maintain your mobility and quality of life [10]. By understanding how the condition behaves and staying vigilant for changes, you can move forward with a clear plan focused on protection, function, and long-term well-being [11].
In this guide
6 chapters
Understanding Your Diagnosis: Mal de Meleda
Learn what Mal de Meleda means, how transgrediens et progrediens palmoplantar keratoderma develops, how it is inherited, and what to discuss with your doctor.
Symptoms and Disease Progression
Learn how Mal de Meleda symptoms progress, including skin spread, sweating, odor, fissures, nail changes, infections, pseudoainhum, and joint contractures.
Diagnosis, Genetics, and Look-Alikes
Learn how Mal de Meleda is diagnosed using clinical findings, SLURP1 genetic testing, biopsy, and comparisons with similar palmoplantar keratoderma conditions.
Standard Medical Treatments
Learn how Mal de Meleda is treated with keratolytics, moisturizers, topical or oral retinoids, and safety monitoring for acitretin, pregnancy, and blood tests.
Daily Skin Care, Mobility, and Hygiene
Learn daily skin care for transgrediens et progrediens palmoplantar keratoderma: control moisture, protect fissures, recognize infection, and support mobility.
Long-Term Monitoring and Complications
Learn how Mal de Meleda is monitored, including contractures, constriction bands, skin cancer warning signs, genetic counseling, and emotional support.
Common questions in this guide
What is Mal de Meleda?
What do transgrediens and progrediens mean in this condition?
How is Mal de Meleda diagnosed?
What treatments can help manage Mal de Meleda?
Can Mal de Meleda affect walking or mobility?
Which specialists are involved in Mal de Meleda care?
Get notified when new evidence is published on Transgrediens et progrediens palmoplantar keratoderma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Mal de Meleda: A Focused Review.
Perez C, Khachemoune A
American journal of clinical dermatology 2016; (17(1)):63-70 doi:10.1007/s40257-015-0157-1.
PMID: 26445964 - 2
Identification of novel homozygous SLURP1 mutation in a Javanese family with Mal de Meleda.
Radiono S, Pramono ZAD, Oh GGK, et al.
International journal of dermatology 2017; (56(11)):1161-1168 doi:10.1111/ijd.13776.
PMID: 29023701 - 3
Atypical Mal de Meleda in a Hispanic Patient.
Guevara M, Mafla M, Miño C
Case reports in dermatological medicine 2023; (2023()):6640311 doi:10.1155/2023/6640311.
PMID: 37744084 - 4
Patient with Mal de Meleda in whom a Novel Gene Mutation was Identified.
Gurel G, Cilingir O, Kutluay O, et al.
The Eurasian journal of medicine 2019; (51(2)):206-208 doi:10.5152/eurasianjmed.2018.18215.
PMID: 31258365 - 5
Clinical and Genetic Findings in Patients With Palmoplantar Keratoderma.
Gram SB, Brusgaard K, Lei U, et al.
JAMA dermatology 2025; (161(2)):157-166 doi:10.1001/jamadermatol.2024.4824.
PMID: 39630431 - 6
Palmoplantar keratodermas: clinical and genetic aspects.
Has C, Technau-Hafsi K
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2016; (14(2)):123-39; quiz 140 doi:10.1111/ddg.12930.
PMID: 26819106 - 7
Pain Hypersensitivity in SLURP1 and SLURP2 Knock-out Mouse Models of Hereditary Palmoplantar Keratoderma.
Weinberg RL, Kim S, Pang Z, et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2024; (44(28)) doi:10.1523/JNEUROSCI.0260-23.2024.
PMID: 38866482 - 8
Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.
Bodemer C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA
The British journal of dermatology 2021; (184(3)):393-400 doi:10.1111/bjd.19144.
PMID: 32307694 - 9
A Case of Mal De Meleda: The Rare Presentation of Palmoplantar Keratoderma Disease.
Kalyan V, Suvvari TK, Kandula VDK, et al.
Cureus 2021; (13(9)):e18061 doi:10.7759/cureus.18061.
PMID: 34692287 - 10
Transgradient Variant of Mal De Meleda Presenting As Palmoplantar Keratoderma: A Case Report.
Khan A, Singh A, Madke B, et al.
Cureus 2024; (16(5)):e60717 doi:10.7759/cureus.60717.
PMID: 38903266 - 11
Japanese guidelines for the management of palmoplantar keratoderma.
Yoneda K, Kubo A, Nomura T, et al.
The Journal of dermatology 2021; (48(8)):e353-e367 doi:10.1111/1346-8138.15850.
PMID: 34121213
This page provides information about Mal de Meleda for educational purposes only and does not replace medical advice. A dermatologist, podiatrist, or genetics professional can interpret your symptoms and testing and tailor care to your situation.